In a similar manner, member states must now pool their resources to address their shared geoeconomic concerns. To achieve ...

More recent news has suggested Neurizon is close to receiving Orphan Designation for the drug in Europe, with European ...

With more than 27 million doses distributed globally, no single sign reported in an adverse event is classified as more than ...

Product development highlights Alvotech announced that the European Medicines Agency (EMA) accepted a Marketing Authorization ...

Continuing to advance the pipeline and remain on-track to engage with the FDA on TP-04 (Papulopustular Rosacea) and TP-05 ...

September 2024: authorization received from The European Medicines Agency to initiate the INVINCIBLE-3 Study in Europe. September 2024: authorization from the Swiss Medic and the Swiss Ethics ...

A major news story from Sanofi this month is that "The European Medicines Agency has approved Dupixent (dupilumab) to treat ...

Cash and cash equivalents of €5.7 million as of September 30, 2024Execution of clinical strategy as planned, with the GLORIA global Phase II study initiation expected in the first quarter of 2025 Lyon ...

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

With more than 27 million doses distributed globally, no single sign reported in an adverse event is classified as more than ...

The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and ...